Non Animal Testing Database
EnglischDeutsch

Automated HER2 assesment in breast cancer

2015
Pathology Friesland, Leeuwarden, Netherlands
Validation of a fully automated "in situ" hybridisation procedure combined with an automated imaging system for HER2-targeted therapy. It was possible to assess HER2 over 328 samples of breast tumour patients and, when compared to previous manual methods, the method showed to have a consistent efficacy. This platform can facilitate the routine assessment of HER2 in breast cancer patients for clinical purposes.
Fully automated fluorescent in situ hybridization (FISH) staining and digital analysis of HER2 in breast cancer: a validation study
Elise MJ van der Logt
#725
Added on: 07-29-2021
Back to Top
English German

Warning: Internet Explorer

The IE from MS no longer understands current scripting languages, the latest main version (version 11) is from 2013 and has not been further developed since 2015.

Our recommendation: Use only the latest versions of modern browsers, for example Google Chrome, Mozilla Firefox or Microsofrt Edge, because only this guarantees you sufficient protection against infections and the correct display of websites!